Scroll To Top

lenacapavir

An HIV breakthrough is here. Let's not let it go to waste

Opinion: "While the obstacles we face may be significant, Lenacapavir represents a monumental breakthrough in the fight against HIV/AIDS, one we can not afford to squander," write Dr. Kelly Gebo and Dr. Amanda Castel.

Twice-yearly injectable lenacapavir, an HIV-prevention drug, reduces risk by 96%

Gilead researchers say lenacapavir “has the potential to be one of the most impactful interventions” in the battle against HIV.